PD-1 inhibitor (antibody)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PD-1 inhibitor (antibody), covering 2025-07-03 to 2025-07-03. Get the full timeline:
Most recent: Clinical Trial Update: Anti PD-1 Plus Postbiotic Versus Anti PD-1 Alone in Locally Advanced or Metastatic, Treatment naïve, Cutaneous Melanoma Study [NA]